DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/1938c2/biotechnology_gl) has announced the addition of the "Biotechnology - Global Strategic Business Report" report to their offering.

The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird's eye view of the Biotechnology industry. Annotated with 26 fact, and data rich tables presenting analytical segmentation by product application, the report provides global revenues, and expenditure on R&D of/by biotechnology companies, sales of enabling technologies, biologic drug sales by product and global biotech/ pharmacogenomics/ bioinformatics product/ technology sales, among others.

The report offers a sneak peek into major end-use industries, taking note of select trends in Genomics, Biochips, Biologics and Biopharmaceutical Intermediates, Biogenerics, Biotechnology Instruments, and Biotechnology Reagents, among others. Also included is a compilation of all recent mergers, acquisitions, and strategic corporate developments. A regional-level of discussion mirrors the prevalent scenario in key regional markets such as the US, Canada, Mexico, Japan, France, Germany, Poland, UK, Sweden, Switzerland, New Zealand, India, Malaysia, and Brazil, among few others. The report also includes an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 2,220 companies worldwide.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying

Key Topics Covered:

- Biotechnology

- Global Market Overview

- Major companies

- Mergers and Acquisitions

- Strategic Corporate Developments

- Product Launches & Developments

- A Regional Market Perspective

- North America

- The United States

- Canada

- Mexico

- Japan

- A European Market Perspective

- Denmark

- France

- Germany

- Italy

- Poland

- United Kingdom

- Sweden

- Switzerland

- Asia-Pacific

- Australia

- New Zealand

- China

- India

- Malaysia

- South Korea

- Taiwan

- Argentina

- Brazil

- Israel

- Global Directory

Companies Mentioned:

- Abbott

- Abraxis BioScience

- Actelion,

- Aldurazyme

- Amgen

- Amylin Pharmaceuticals

- Aranesp

- AstraZeneca

- Avastin

- Aventis Group

- Benefix,

- Biogen Idec

- CSL,

- Celera Genomics

- Celgene

- Cephalon

- Chiron

- CuraGen

- Elan

- Eli Lilly

- Enbrei

- Enbrel

- Epogen

- Eprex

- Erbitux,

- Factors Novoseven

- Genentech

- Genzyme

- Gilead Sciences

- GlaxoSmithKline

- Gonal-F

- Herceptin

- Human Genome Sciences

- Humira

- ImClone Systems

- Incyte

- Johnson & Johnson

- Kogenate

- Lantus

- Lexicon Genetics,

- MGI

- MabThera/Rituxan

- Maxygen,

- MedImmune

- Merck

- Millennium Pharmaceuticals

- Myriad Genetics

- Neo-Recormon

- Neulast

- Neulasta

- Neupogen

- Neutrogin

- Novartis

- Novo Nordisk

- OSI Pharmaceuticals

- PDL BioPharma

- Pegintron

- Pfizer

- Pharma

- Procrit

- Puregon

- Rebif

- Refacto

- Remicade

- Rituxan

- Roche

- Roche Genentech

- Sanofi-Aventis

- Serono

- UCB SA

- Wyeth

For more information visit http://www.researchandmarkets.com/research/1938c2/biotechnology_gl

Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716